Previous Article | Next Article 
Infection and Immunity, July 2001, p. 4572-4579, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4572-4579.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Establishment of a Persistent Escherichia
coli Reservoir during the Acute Phase of a Bladder
Infection
Matthew A.
Mulvey,
Joel D.
Schilling, and
Scott J.
Hultgren*
Department of Molecular Microbiology and
Microbial Pathogenesis, Washington University School of Medicine,
St. Louis, Missouri 63110
Received 23 February 2001/Returned for modification 30 March
2001/Accepted 5 April 2001
 |
ABSTRACT |
The vast majority of urinary tract infections are caused by strains
of uropathogenic Escherichia coli that encode
filamentous adhesive organelles called type 1 pili. These structures
mediate both bacterial attachment to and invasion of bladder epithelial cells. However, the mechanism by which type 1 pilus-mediated bacterial invasion contributes to the pathogenesis of a urinary tract infection is unknown. Here we show that type 1-piliated uropathogens can invade
the superficial epithelial cells that line the lumenal surface of the
bladder and subsequently replicate, forming massive foci of
intracellular E. coli termed bacterial factories. In
response to infection, superficial bladder cells exfoliate and are
removed with the flow of urine. To avoid clearance by exfoliation,
intracellular uropathogens can reemerge and eventually establish a
persistent, quiescent bacterial reservoir within the bladder mucosa
that may serve as a source for recurrent acute infections. These
observations suggest that urinary tract infections are more chronic and
invasive than generally assumed.
 |
INTRODUCTION |
Uropathogenic Escherichia
coli (UPEC), the primary cause of urinary tract infections (UTIs)
(16, 35), is not generally regarded as an invasive
pathogen. Infections caused by UPEC are typically self-limiting and
UPEC rarely spreads beyond the urinary tract (17, 35).
Adherence of UPEC to host epithelial cells within the bladder and other
tissues within the urinary tract is considered critical to the ability
of UPEC to cause disease (2, 12, 33). Filamentous adhesive
organelles called type 1 pili, which are encoded by virtually all UPEC
isolates (25), can mediate bacterial attachment to host
bladder cells and have been shown to be significant virulence factors
associated with UTIs (6, 24, 25, 29, 37). These structures
contain an adhesin molecule, FimH, that binds mannose-containing
glycoprotein receptors expressed on the lumenal surface of the bladder
(23, 38). In addition to mediating bacterial attachment,
recent work has shown that the FimH adhesin can also directly stimulate
host cell signaling cascades that lead to the induction of cytoskeletal rearrangements and the envelopment and internalization of adherent UPEC
(27). These findings have suggested that the invasion of bladder epithelial cells by type 1-piliated UPEC may have an
as-yet-appreciated role in the pathogenesis of UTIs.
Data from various experimental systems indicate that invasion of
eukaryotic cells can provide bacterial pathogens refuge from both
innate and adaptive host defenses and may also facilitate the
dissemination of microbes within and across tissue barriers (8). Within the urinary tract, the bladder epithelium
functions as a formidable physical barrier, preventing the diffusion of urine and other substances from within the bladder lumen (15, 26). The bladder epithelium, which is composed of a single layer of large, highly differentiated superficial cells overlying two or
three layers of small, relatively undifferentiated basal and intermediate epithelial cells, also serves as an active component of
the innate immune system. Interactions between type 1-piliated UPEC and
bladder epithelial cells can stimulate cytokine and chemokine production and can also trigger the exfoliation and clearance of
superficial epithelial cells (29, 34, 36). Exfoliation of
infected bladder cells occurs via an apoptosis-like mechanism and
appears to be an effective host defense strategy (29). To colonize the bladder successfully, UPEC must have a means of
counteracting or circumventing bladder cell exfoliation and other
innate host defenses within the urinary tract.
Here we report that following invasion of superficial bladder
epithelial cells, UPEC can replicate intracellularly and eventually reemerge from the infected host cells in a manner reminiscent of a
lytic virus cycle. Upon exiting the superficial cells, UPEC can
interact with and invade surrounding and underlying epithelial cells,
leading to the establishment of a quiescent bacterial reservoir within
the bladder tissue. These findings suggest a means by which invasion,
rather than promoting bacterial spread across mucosal layers and into
other tissues, can facilitate the localized persistence of a bacterial pathogen.
 |
MATERIALS AND METHODS |
Bacterial strains.
The clinical cystitis isolate NU14 has
been described previously (19, 25). Other cystitis
isolates, including UTI89, were kindly provided by S. Langermann. The
K-12 strains MG1655 and AAEC185 (
type 1 gene cluster), the latter
of which was complemented with plasmid pSH2 (31), which
encodes the type 1 pilus gene cluster, have been described previously
(3, 4, 29). All bacterial strains were grown in static
Luria-Bertani (LB) broth at 37°C for 48 h to induce expression
of type 1 pili. Expression was verified by mannose-sensitive
agglutination of a 3% solution of guinea pig erythrocytes
(A640 of
1.9) or a 1% solution of baker's yeast in phosphate-buffered saline (PBS).
Inoculations of mice and microscopy.
Eight- to ten-week-old
female C57BL/6 mice (Jackson Laboratories) were anesthetized with
methoxyflurane and inoculated via transurethral catheterization with 50 µl of a bacterial suspension (
108 CFU) in
PBS as previously described (29). At the indicated times,
mice were killed by cervical dislocation under anesthesia and their
bladders were aseptically removed, weighed, and homogenized in 1 ml of
0.025% Triton X-100-PBS. For the results of the experiment shown in
Fig. 1B, when possible, urine released at
the time of death was collected from infected mice in Eppendorf tubes.
Bacterial titers were determined by plating serial dilutions of
homogenates or urine on LB agar plates.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Kinetics of bacterial clearance from the bladder
following infection with type 1-piliated UPEC. (A) The majority of
bacteria were cleared within the first 48 h after infection of
C57BL/6 mice with UTI89. (B) Significant numbers of bacteria, however,
persist within the bladder tissue up to 6 weeks after infection. In
addition, the bacteriologic status of urine samples collected from each
mouse at the time of death is also indicated in panel B. , urine
titer of >103 CFU/ml; , urine titer of
<103 CFU/ml; , no urine collected. Horizontal lines
indicate the median titer at each time (n = 5 or
6).
|
|
Hematoxylin and eosin staining and immunofluorescence microscopy
were performed as described previously (34). Electron and confocal microscopy analyses of mouse bladders have been previously described (27, 29).
Intracellular growth assays.
The 5637 bladder epithelial
cells (ATCC HTB-9) were seeded into 24-well plates and grown to
confluency in RPMI 1640 medium supplemented with 10% fetal bovine
serum (Sigma), 2 g of sodium bicarbonate per liter, and 0.3 g
of L-glutamine per liter. In two sets of triplicate wells,
bladder cells were infected with a multiplicity of infection of 5 to10
bacteria per host cell (20 µl of a bacterial solution diluted in LB
broth [A600 of ~0.5]). Bacterial contact with host cells was expedited by centrifugation of
plates at 600 × g for 5 min. After 2 h of
incubation at 37°C, medium was replaced with 1.5 ml of fresh medium
containing 100 µg of gentamicin (Sigma)/ml to kill any extracellular
bacteria. In duplicate sets of wells, medium containing gentamicin and
trimethoprim-sulfamethoxazole (TMP-SMZ) (54 and 270 µg/ml,
respectively) was added to the host cells to inhibit intracellular
bacterial growth and to kill any extracellular bacteria. After an
additional 2-hour incubation, cells were washed once with PBS (with
Mg2+/Ca2+) and fresh medium
containing 15 µg of gentamicin/ml (with or without TMP-SMZ) was added
to the cells. This submaximal concentration of gentamicin prevented
extracellular bacterial growth and reduced the chances of gentamicin
leaching into the host cells during longer incubation times. At the
indicated times, host cells were washed three times in PBS and lysed in
1 ml of 0.1% Triton X-100-double-distilled H2O
(ddH2O). Lysates were plated on LB agar plates to
determine numbers of surviving intracellular bacteria.
Bacterial fluxing assays.
The 5637 cells in 24-well plates
were infected and incubated in the presence of gentamicin as described
for the intracellular growth assays. At 24 h after the addition of
gentamicin, host cells were washed five times with PBS (with
Mg2+/Ca2+). One set of
triplicate wells was lysed to determine the number of intracellular
bacteria surviving the 24-hour incubation in the presence of
gentamicin. Fresh medium (980 µl) with or without 15 µg of
gentamicin/ml was added to the remaining triplicate sets of wells, and
these mixtures were incubated for an additional 7 h at 37°C.
Twenty microliters of 5% Triton X-100-ddH2O was
added directly to the wells lacking gentamicin, and lysates were plated to determine the total number of intra- and extracellular bacteria. Wells containing gentamicin were washed three times with PBS prior to
lysis in 1 ml of 0.1% Triton X-100-ddH2O.
 |
RESULTS |
Establishment and persistence of a UTI
A mouse
cystitis model was used to examine the capacity of UPEC to resist
clearance and to persist within the bladder. Female C57BL/6 mice were
inoculated via transurethral catheterization with the type 1-piliated
clinical cystitis isolate, UTI89, and bacterial titers were determined
at various times. Between 2 and 12 h after inoculation, the number
of bacteria within the bladder decreased substantially (an average of 3 log units) (Fig. 1A). The reduction of titers during the first
12 h of infection correlates with massive exfoliation of the
superficial cells in C57BL/6 mice and with the influx of neutrophils
into the bladder tissue in response to infection (29, 30).
Despite these and other innate host defenses, however, considerable
numbers of bacteria were able to avoid rapid clearance from the bladder
during the first 2 days of the infection. From 2 to 7 days after
infection, bacteria persisted within the bladder at fairly constant
levels (Fig. 1A), and bacterial titers often remained substantially
high and stable for at least 6 weeks (Fig. 1B). Interestingly, after 2 days of infection, bacteria were undetectable in 58% of the urine
samples collected at the time of death from infected mice, even though bacteria persisted in the bladder tissue. These data are in agreement with those of a previous study suggesting that urine titers do not
necessarily reflect the bacteriologic status of the bladder tissue
(18). Similar infections comparing the cystitis strain NU14 with the fimH isogenic mutant strain, NU14-1, were
also performed. At 14 days after infection, 75% of the bladders
from NU14-infected mice remained colonized (mean titer, 160 CFU/bladder), whereas the bladders of all four mice infected with
NU14-1 remained sterile.
Invasion of the bladder epithelium.
The ability of UPEC to
resist rapid clearance from the bladder is potentially linked to the
capacity of UPEC to invade the bladder epithelium. Within 48 h
after infection with UPEC, the majority of bacteria that persist within
infected mouse bladders are protected from the bactericidal effects of
gentamicin treatment ex vivo (29). Furthermore, the in
vivo treatment of infected mice with gentamicin, cefuroxime, or the
bacteriostatic drug combination TMP-SMZ fails to substantially reduce
bacterial titers within the bladder tissue, although these antibiotics
are able to effectively sterilize the urine (20, 30). Such
observations are consistent with the possibility that UPEC might enter
a protective niche within the bladder tissue during a UTI.
Histological examination of C57BL/6 mouse bladders recovered 2 h
after inoculation with UTI89 demonstrated that UPEC could penetrate the
superficial epithelial cells lining the lumenal surface of the bladder
(Fig. 2A and B). Multiple bacteria could invade a single superficial cell, although the bacteria did not enter
the host cells en masse. No large groups of intracellular bacteria were
observed at this time, and bacteria were not detected within the small,
underlying intermediate and basal epithelial cells. These observations
support previous transmission and scanning electron microscopy studies
which found that UPEC can enter superficial bladder cells in vivo
(11, 28, 29).

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 2.
Replication of UPEC within superficial bladder cells. (A
and B).Two hours after infection of C57BL/6 mice with UTI89, bacteria
were detected in hematoxylin-and-eosin-stained sections entering or
already within the superficial epithelial cells lining the lumenal
surface of the bladder (arrowheads). (C to E) By 6 h after
inoculation, large foci of intracellular E. coli were
apparent within many of the superficial bladder cells. (E) Bacteria
(red) were stained using an anti-E. coli primary
antibody and Cy3-labeled secondary antibody. Host cell nuclei were
visualized using Hoechst dye. Bars, 10 µm.
|
|
By 6 h after inoculation of C57BL/6 mice with UTI89, most of the
superficial cells had exfoliated in response to the
infection (11). Within many of the
remaining superficial cells, however, large inclusions of intracellular
bacteria were present (Fig. 2C and D). Immunohistological staining
confirmed that the intracellular organisms were E. coli
(Fig. 2E). Bacteria were not detected in bladder sections from
mock-infected mice. No large accumulations of bacteria were seen within
the underlying intermediate and basal epithelial cells, although
individual bacteria were occasionally observed within these bladder
cells at this and later times. These observations suggest that UTI89
can replicate effectively within the superficial cells but may have a
diminished capacity to multiply within the less differentiated
underlying bladder epithelium. In contrast to UTI89 and several other
clinical UTI E. coli isolates examined, the laboratory K-12
strains AAEC185/pSH2 and MG1655, which express type 1 pili and are able
to invade superficial cells in vivo (11; M. A. Mulvey, J. D. Schilling, and S. J. Hultgren, unpublished observations), did not
appear to replicate within the host cells and did not form large
intracellular inclusions. These data indicate that UPEC strains may
encode specific virulence factors, which are missing in laboratory K-12
strains such as AAEC185/pSH2 and MG1655, that enable UPEC to multiply
within host superficial bladder cells, essentially converting the host
cells into bacterial factories.

View larger version (151K):
[in this window]
[in a new window]
|
FIG. 3.
Efflux of UPEC from superficial bladder epithelial
cells. (A and B) Six hours after infection with type 1-piliated UPEC,
the superficial bladder cell layer was in the process of undergoing
exfoliation. The remaining superficial cells often appeared swollen
with evidence of membrane blebbing. (B) Bacteria frequently appeared to
be spilling out from within the superficial cells. (C to G) Elongated
forms of bacteria, along with their normal-sized counterparts, were
observed seemingly emerging from within superficial cells and spilling
onto underlying and surrounding epithelial cells. (E) Filamentous
bacteria were sometimes seen bridging ss host cell sutures and
interacting with two adjoining superficial cells simultaneously.
(Inset) The elongated bacteria contained at least partial septa at
variable distances along their lengths. (G) Examination of
hematoxylin-and-eosin-stained bladder sections indicated that the
filamentous forms of bacteria could extend a significant distance
through the interior of the superficial bladder cells. Bars, 5 µm (A
to F) and 10 µm (G).
|
|
Evasion of the exfoliation response.
The exfoliation and
clearance of infected superficial cells pose a significant challenge to
the persistence of UPEC within the bladder (1, 7, 11, 29).
Without the ability of UPEC to escape from dying and exfoliating host
epithelial cells, UPEC invasion of the superficial bladder cells could
be considered a dead-end process as far as bacterial survival within
the bladder is concerned. To understand how UPEC might resist clearance
by exfoliation, we used scanning electron microscopy to examine C57BL/6 mouse bladders recovered 6 h after inoculation with UTI89 and other type 1-piliated UPEC isolates. At this time, exfoliation of the
superficial cells was apparent and many of the underlying, smaller and
less differentiated intermediate epithelial cells were exposed. The
superficial cells remaining had lost their normal, distinctive
pentagonal and hexagonal outlines, appeared shrunken, and frequently
displayed membrane blebbing characteristic of apoptotic cells (Fig. 3A
to C). Virtually all of the remnants of the superficial cells had at
least a few surface-localized bacteria. Occasionally, the host
superficial cells appeared bloated in regions, possibly as a result of
large inclusions of intracellular E. coli as can be observed
in Fig. 2C to E. Large numbers of UPEC organisms were often observed on
the surfaces of the dying superficial cells and, in many cases,
appeared to be erupting from within the host cells (Fig. 3B and C).
The bacteria associated with the dying superficial cells at 6 h
after inoculations were frequently elongated, sometimes reaching lengths of greater than 50 µm (Fig. 3C to G). The elongated bacteria possessed partial septa at variable distances along their lengths (Fig.
3E, inset). In many instances, bacteria appeared to be spilling out of
infected superficial cells and colonizing adjacent and underlying host
cells (Fig. 3C and D). The filamentous bacteria were observed exiting,
and/or entering, superficial cells through tight openings in the host
cell membrane (Fig. 3E and F) and were occasionally seen looping within
and between adjacent superficial cells (Fig. 3E and F). Histological
examination of bladder sections from infected mice also revealed
filamentous bacteria protruding into the lumen from within superficial
cells (Fig. 3G). These various observations suggest that UPEC has the
capacity to replicate within superficial bladder cells and subsequently
to escape before the host cells completely exfoliate and are cleared
from the urinary tract by micturition.
Intracellular persistence and reemergence of UPEC.
The ability
of UPEC to persist within and reemerge from infected bladder epithelial
cells was confirmed by in vitro assays. Previous work demonstrated that
E. coli strains expressing type 1 pili can invade 5637 cells
and other bladder epithelial cell lines (27). In a
modified gentamicin protection assay, in which extracellular bacteria
are selectively killed, the intracellular titers of the cystitis
isolates UTI89 and NU14 remained fairly constant within 5637 cells over
the course of a 48-hour infection (Fig.
4A). In contrast, the intracellular
titers of the laboratory K-12 strains AAEC185/pSH2 (which expresses
type 1 pili encoded by the pSH2 plasmid) and MG1655 (which expresses
type 1 pili encoded on the chromosome) decreased continuously
throughout the assay (Fig. 4A). The coaddition of the
membrane-permeating, bacteriostatic antibiotic TMP-SMZ blocked
bacterial survival of the clinical strains but had no effect on the
K-12 strains, suggesting that intracellular persistence is in fact a
dynamic process that requires intracellular replication (Fig. 4A).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
In vitro intracellular persistence and reemergence of
UPEC. 5637 bladder epithelial cells were infected with uropathogenic
isolates (UTI 89 or NU14) or with a laboratory K-12 strain
(AAEC185/pSH2 or MG1655) that expresses type 1 pili, and intracellular
growth assays were performed in the presence of gentamicin. (A)
Intracellular levels of UTI89 and NU14 remained constant for 48 h
in the presence of gentamicin alone. In contrast, intracellular titers
of the K-12 strains decreased significantly during the same time
interval. Inhibition of bacterial replication using the bacteriostatic
antibiotics TMP-SMZ greatly reduced the ability of the clinical
isolates to survive intracellularly. TMP-SMZ had no effect on the
persistence profile of the K-12 strains. (B) Bacterial fluxing assays
indicate that intracellular UPEC isolates can exit host 5637 bladder
cells. Following a 24-hour incubation of infected host cells in the
presence of gentamicin, the cell culture medium was replaced with fresh
medium with and without gentamicin. Within 7 h after removal of
gentamicin (to allow extracellular bacterial growth), the titers of
total extra- and intracellular UTI89 cells greatly increased. In
contrast, the titers of MG1655 remained nearly unchanged regardless of
the absence or continued presence of gentamicin.
|
|
The in vivo images of UPEC during an acute infection suggest that the
ability of E. coli to reemerge from infected cells may be a
critical event in UTI pathogenesis. To examine the capacity of UTI89
and other type 1-piliated strains to exit host bladder epithelial
cells, bacteria were allowed to invade 5637 bladder cells and the cells
were then incubated in the presence of gentamicin for 24 h. Next,
the cell culture medium was replaced with fresh medium with and without
gentamicin, and bacterial titers were determined after an additional
7 h of incubation. During this latter incubation in the absence of
gentamicin, total UTI89 titers increased significantly, while little
increase was observed in the continued presence of gentamicin (Fig.
4B). NU14 behaved similarly (Mulvey et al., unpublished observations).
These data indicate that intracellular UPEC can emerge from host
bladder cells and subsequently multiply in the cell culture medium when
gentamicin is removed. In contrast, MG1655 titers remained nearly
constant during the 7-hour incubation with and without gentamicin (Fig. 4B), despite the fact that these bacteria can multiply as efficiently as UTI89 when delivered into cell culture medium lacking antibiotics. Thus, relative to the UPEC strains, the intracellular type 1-piliated K-12 strains have a decreased capacity to exit host bladder epithelial cells.
Microscopic examination of 5637 cells maintained in
gentamicin-containing medium for 1 to 3 days after infection with
either UTI89 or NU14 (Fig. 5) showed that
these pathogens could form large intracellular inclusions similar to
the bacterial factories seen in in vivo studies (Fig. 2C to E). The
intracellular bacteria observed within 5637 cells by transmission
electron microscopy (Fig. 5A) or by confocal microscopy (Fig. 5B and C)
crowded the host cell cytoplasm, and some bacteria were filamentous,
reminiscent of the elongated microbes observed in infected mouse
bladders (Fig. 3). The addition of TMP-SMZ blocked the formation of
these intracellular bacterial factories (Mulvey et al., unpublished observations). Most of the infected 5637 bladder cells within a
monolayer, rather than being inundated with E. coli,
harbored only one or a few bacteria, suggesting that intracellular
environmental factors may influence whether UPEC begins to multiply
within an individual host cell. In contrast to the UPEC strains, the
K-12 strains did not form large intracellular inclusions, consistent with in vitro growth assays (Fig. 4A) and in vivo microscopic data
indicating that these organisms do not multiply efficiently within
bladder epithelial cells.

View larger version (119K):
[in this window]
[in a new window]
|
FIG. 5.
In vitro formation of intracellular bacterial
inclusions. (A) One day after infection of 5637 cells with UTI89, large
foci of intracellular bacteria were detected within 5637 cells by
transmission electron microscopy. (B and C) Similar inclusions of
intracellular bacteria were visualized by confocal microscopic
examination of 5637 cells 72 h after infection with NU14
constitutively expressing green fluorescent protein. Host cells were
counterstained with propidium iodide. Gentamicin prevented
extracellular bacterial growth during these assays.
|
|
 |
DISCUSSION |
According to prevailing assumptions, UPEC strains are strictly
extracellular pathogens. In this study, however, we provide evidence
that host cell invasion enhances the ability of UPEC to successfully
infect the bladder epithelium. Upon making contact with superficial
epithelial cells in the bladder lumen, type 1-piliated UPEC induces a
cascade of signaling events leading to bacterial internalization
(27, 29). Following internalization UPEC is able to
replicate, resulting in the formation of large collections of
intracellular bacteria, which due to their appearance we have termed
bacterial factories. UPEC strains were also shown to have the capacity
to flux out of bladder epithelial cells, a process that may allow
bacteria to escape from host superficial cells that are induced to
exfoliate in response to infection. Bacteria exiting dying host cells
are often filamentous, enabling them to maintain contact with the
bladder epithelium as they leave one host cell and interact with
neighboring and underlying epithelial cells. In comparison with the
UPEC isolates, type 1-piliated K-12 E. coli strains MG1655
and AAEC185/pSH2, although able to invade bladder epithelial cells,
were unable to persist, multiply intracellularly, or effectively exit
the host cells. Furthermore, relative to UPEC, the K-12 strains are
cleared more rapidly from the bladder during an acute infection (Mulvey
et al., unpublished observations), suggesting that intracellular
replication and the fluxing activity of UPEC enhance bacterial survival
in vivo.
These observations illustrate the dynamic complexity of host-pathogen
interactions during the acute phase of an infection. While exfoliation
of superficial bladder cells is an effective host defense (1, 7,
11, 29), the shedding of infected host cells with the flow of
urine may also facilitate the spread of UPEC in the environment. In
addition, the exfoliation of infected superficial cells provides an
opportunity for UPEC to interact with and invade the underlying bladder
epithelium. Thus, it appears that UPEC can utilize invasion at two
distinct steps in the establishment of an infection. Initially,
invasion of bladder superficial cells provides UPEC with a protective,
but transient, environment in which the bacteria can replicate.
Subsequently, bacteria that manage to avoid rapid clearance from the
urinary tract can invade the underlying epithelium, where they can
establish a more stable bacterial reservoir. This reservoir can persist
for several weeks in a quiescent state, seemingly undetected by immune
surveillance mechanisms and protected from antibiotics (20, 29,
30), possibly by virtue of the permeability barrier maintained
by the bladder epithelium (15, 26). Potentially, signals
from differentiating bladder epithelial cells or other environmental
cues may trigger intracellular bacterial replication and the
reemergence of the bacterial reservoir, leading to a recurrent acute infection.
Type 1 pili were shown to be critical for bacterial persistence in the
bladder as strain NU14 establishes persistent long-lasting infections
while the fimH mutant strain NU14-1 is rapidly cleared from
the bladders of infected mice. In contrast, it has been shown that type
1 pili do not contribute to bacterial persistence in a mouse model of
pyelonephritis (14). Therefore, the effect of type 1 pili
appears to be localized to the bladder, whereas other adhesive factors
such as Dr adhesins and P pili have been shown to be critical for
establishing persistent kidney infections (13, 32).
Epidemiologic studies have also correlated Dr family adhesins and class
III PapG with chronic or recurrent UTIs (9); however, the
importance of type 1 pili in bacterial persistence has likely been
underappreciated in these clinical studies due to the ubiquitous nature
of the fim gene cluster in all strains of E. coli.
UTIs, which affect at least 25% of women, have a strong propensity to
recur (16). Within 6 months after an initial UTI, about
one-fourth of women will experience a second infection and many
individuals will endure multiple, recurrent UTIs throughout their lives
(10, 16). Recurrent UTIs are usually attributed to the
reinoculation of the urinary tract with uropathogens arising from
intestinal or other environmental reservoirs. Intriguingly, the
bacteria associated with a recurrent UTI often appear to be phenotypically or genotypically identical to the bacterial strain that
caused the initial infection (5, 10, 21, 22). Based on
such observations, it is feasible that many recurrent UTIs occur due to
a resurgence of UPEC from quiescent reservoirs established within the
bladder mucosa following an initial acute infection. Therefore, in many
instances, the tendency of UTIs to recur may be directly linked to the
ability of UPEC to replicate intracellularly and eventually reemerge
from infected bladder epithelial cells. Other bacterial pathogens that
have been traditionally considered to be noninvasive may use strategies
similar to that of UPEC to establish long-term, quiescent bacterial
reservoirs in other tissues. The existence of such reservoirs may help
explain the recurrent nature of many infectious diseases.
 |
ACKNOWLEDGMENTS |
M.A.M. and J.D.S. contributed equally to this work.
We thank M. Veith for his excellent assistance with scanning electron
microscopy, M. Levy for help with transmission electron microscopy, and
J. J. Martinez for help with confocal microscopy. We are also
grateful to K. Dodson, M. Chapman, and C. Vincent for helpful
discussions and suggestions.
This work was supported by grants AI29549, DK51406, and AI48 from the
National Institutes of Health (S.J.H.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Microbiology and Microbial Pathogenesis, Box 8230, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-3667. Fax: (314) 362-1998. E-mail: hultgren{at}borcim.wustl.edu.
Present address: Department of Pathology, University of Utah School
of Medicine, Salt Lake City, UT 84132.
Editor:
A. D. O'Brien
 |
REFERENCES |
| 1.
|
Aronson, M.,
O. Medalia,
D. Amichay, and O. Nativ.
1988.
Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism.
Infect. Immun.
56:1615-1617[Abstract/Free Full Text].
|
| 2.
|
Barza, M.
1998.
Urinary tract, p. 564-572.
In
M. Schaeter, N. C. Engelberg, B. I. Eisenstein, and G. Medoff (ed.), Mechanisms of microbial disease. Williams & Wilkins, Philadelphia, Pa.
|
| 3.
|
Blattner, F. R.,
G. Plunkett III,
C. A. Bloch,
N. T. Perna,
V. Burland,
M. Riley,
J. Collado-Vides,
J. D. Glasner,
C. K. Rode,
G. F. Mayhew,
J. Gregor,
N. W. Davis,
H. A. Kirkpatrick,
M. A. Goeden,
D. J. Rose,
B. Mau, and Y. Shao.
1997.
The complete genome sequence of Escherichia coli K-12.
Science
277:1453-1474[Abstract/Free Full Text].
|
| 4.
|
Blomfield, I. C.,
M. S. McClain, and B. I. Eisenstein.
1991.
Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants.
Mol. Microbiol.
5:1439-1445[Medline].
|
| 5.
|
Brauner, A.,
S. H. Jacobson, and I. Kuhn.
1992.
Urinary Escherichia coli causing recurrent infections-a prospective follow-up of biochemical phenotypes.
Clin. Nephrol.
38:318-323[Medline].
|
| 6.
|
Connell, I.,
W. Agace,
P. Klemm,
M. Schembri,
S. Marild, and C. Svanborg.
1996.
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Proc. Natl. Acad. Sci. USA
93:9827-9832[Abstract/Free Full Text].
|
| 7.
|
Davis, C. P.,
D. T. Uehling,
K. Mizutani, and E. Balish.
1978.
Bladder surface alteration following infection with Escherichia coli, p. 315-320.
In
R. P. Becker, and O. Johari (ed.), Scanning electron microscopy, vol. II. AMF, O'Hare, Ill.
|
| 8.
|
Finlay, B. B., and P. Cossart.
1997.
Exploitation of mammalian host cell functions by bacterial pathogens.
Science
276:718-725[Abstract/Free Full Text]. (Erratum, 278:373.)
|
| 9.
|
Foxman, B.,
B. Gillespie,
J. Koopman,
L. Zhang,
K. Palin,
P. Tallman,
J. V. Marsh,
S. Spear,
J. D. Sobel,
M. J. Marty, and C. F. Marrs.
2000.
Risk factors for second urinary tract infection among college women.
Am. J. Epidemiol.
151:1194-1205[Abstract/Free Full Text].
|
| 10.
|
Foxman, B.,
L. Zhang,
P. Tallman,
K. Palin,
C. Rode,
C. Bloch,
B. Gillespie, and C. F. Marrs.
1995.
Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.
J. Infect. Dis.
172:1536-1541[Medline].
|
| 11.
|
Fukushi, Y.,
S. Orikasa, and M. Kagayama.
1979.
An electron microscopic study of the interaction between vesical epithelium and E. coli.
Investig. Urol.
17:61-68[Medline].
|
| 12.
|
Funfstuck, R.,
J. W. Smith,
H. Tschape, and G. Stein.
1997.
Pathogenetic aspects of uncomplicated urinary tract infection: recent advances.
Clin. Nephrol.
47:13-18[Medline].
|
| 13.
|
Goluszko, P.,
S. L. Moseley,
L. D. Truong,
A. Kaul,
J. R. Williford,
R. Selvarangan,
S. Nowicki, and B. Nowicki.
1997.
Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.
J. Clin. Investig.
99:1662-1672[Medline].
|
| 14.
|
Gupta, R.,
N. K. Ganguly,
V. Ahuja,
K. Joshi, and S. Sharma.
1995.
An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
J. Med. Microbiol
43:33-36[Abstract].
|
| 15.
|
Hicks, R. M.
1975.
The mammalian bladder: an accommodating organ.
Biol. Rev. (Cambridge)
50:215-247.
|
| 16.
|
Hooton, T. M., and W. E. Stamm.
1997.
Diagnosis and treatment of uncomplicated urinary tract infection.
Infect. Dis. Clin. N. Am.
11:551-581[CrossRef][Medline].
|
| 17.
|
Hopkins, W. J.,
A. Gendron-Fitzpatrick,
E. Balish, and D. T. Uehling.
1998.
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
Infect. Immun.
66:2798-2802[Abstract/Free Full Text].
|
| 18.
|
Hultgren, S. J.,
T. N. Porter,
A. J. Schaeffer, and J. L. Duncan.
1985.
Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
Infect. Immun.
50:370-377[Abstract/Free Full Text].
|
| 19.
|
Hultgren, S. J.,
W. R. Schwan,
A. J. Schaeffer, and J. L. Duncan.
1986.
Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli.
Infect. Immun.
54:613-620[Abstract/Free Full Text].
|
| 20.
|
Hvidberg, H.,
C. Struve,
K. A. Krogfelt,
N. Christensen,
S. N. Rasmussen, and N. Frimodt-Moller.
2000.
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
Antimicrob. Agents Chemother.
44:156-163[Abstract/Free Full Text].
|
| 21.
|
Ikaheimo, R.,
A. Siitonen,
T. Heiskanen,
U. Karkkainen,
P. Kuosmanen,
P. Lipponen, and P. H. Makela.
1996.
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women.
Clin. Infect. Dis.
22:91-99[Medline].
|
| 22.
|
Jacobson, S. H.,
I. Kuhn, and A. Brauner.
1992.
Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring.
Scand. J. Urol. Nephrol.
26:373-377[Medline].
|
| 23.
|
Jones, C. H.,
J. S. Pinkner,
R. Roth,
J. Heuser,
A. V. Nicholes,
S. N. Abraham, and S. J. Hultgren.
1995.
FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae.
Proc. Natl. Acad. Sci. USA
92:2081-2085[Abstract/Free Full Text].
|
| 24.
|
Langermann, S.,
R. Mollby,
J. E. Burlein,
S. R. Palaszynski,
C. G. Auguste,
A. DeFusco,
R. Strouse,
M. A. Schenerman,
S. J. Hultgren,
J. S. Pinkner,
J. Winberg,
L. Guldevall,
M. Soderhall,
K. Ishikawa,
S. Normark, and S. Koenig.
2000.
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
J. Infect. Dis.
181:774-778[CrossRef][Medline].
|
| 25.
|
Langermann, S.,
S. Palaszynski,
M. Barnhart,
G. Auguste,
J. S. Pinkner,
J. Burlein,
P. Barren,
S. Koenig,
S. Leath,
C. H. Jones, and S. J. Hultgren.
1997.
Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Science
276:607-611[Abstract/Free Full Text].
|
| 26.
|
Lewis, S. A.
2000.
Everything you wanted to know about the bladder epithelium but were afraid to ask.
Am. J. Physiol. Renal Physiol.
278:F867-F874[Abstract/Free Full Text].
|
| 27.
|
Martinez, J. J.,
M. A. Mulvey,
J. D. Schilling,
J. S. Pinkner, and S. J. Hultgren.
2000.
Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
EMBO J.
19:2803-2812[CrossRef][Medline].
|
| 28.
|
McTaggart, L. A.,
R. C. Rigby, and T. S. Elliott.
1990.
The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis.
J. Med. Microbiol.
32:135-141[Abstract].
|
| 29.
|
Mulvey, M. A.,
Y. S. Lopez-Boado,
C. L. Wilson,
R. Roth,
W. C. Parks,
J. Heuser, and S. J. Hultgren.
1998.
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
Science
282:1494-1497[Abstract/Free Full Text]. (Erratum, 283:795, 1999.)
|
| 30.
|
Mulvey, M. A.,
J. D. Schilling,
J. J. Martinez, and S. J. Hultgren.
2000.
From the cover: bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
Proc. Natl. Acad. Sci. USA
97:8829-8835[Abstract/Free Full Text].
|
| 31.
|
Orndorff, P. E., and S. Falkow.
1984.
Organization and expression of genes responsible for type 1 piliation in Escherichia coli.
J. Bacteriol.
159:736-744[Abstract/Free Full Text].
|
| 32.
|
Roberts, J. A.,
B. I. Marklund,
D. Ilver,
D. Haslam,
M. B. Kaack,
G. Baskin,
M. Louis,
R. Mollby,
J. Winberg, and S. Normark.
1994.
The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract.
Proc. Natl. Acad. Sci. USA
91:11889-11893[Abstract/Free Full Text].
|
| 33.
|
Schaeffer, A. J.
1991.
Potential role of phase variation of type 1 pili in urinary tract infection and bacterial prostatitis.
Infection
19(Suppl. 3):S144-S149.
|
| 34.
|
Schilling, J. D.,
M. A. Mulvey,
C. D. Vincent,
R. G. Lorenz, and S. J. Hultgren.
2001.
Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
J. Immunol.
166:1148-1155[Abstract/Free Full Text].
|
| 35.
|
Svanborg, C., and G. Godaly.
1997.
Bacterial virulence in urinary tract infection.
Infect. Dis. Clin. N. Am.
11:513-529[CrossRef][Medline].
|
| 36.
|
Svanborg, C.,
G. Godaly, and M. Hedlund.
1999.
Cytokine responses during mucosal infections: role in disease pathogenesis and host defence.
Curr. Opin. Microbiol.
2:99-105[CrossRef][Medline].
|
| 37.
|
Thankavel, K.,
B. Madison,
T. Ikeda,
R. Malaviya,
A. H. Shah,
P. M. Arumugam, and S. N. Abraham.
1997.
Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
J. Clin. Investig.
100:1123-1136[Medline].
|
| 38.
|
Wu, X. R.,
T. T. Sun, and J. J. Medina.
1996.
In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
Proc. Natl. Acad. Sci. USA
93:9630-9635[Abstract/Free Full Text].
|
Infection and Immunity, July 2001, p. 4572-4579, Vol. 69, No. 7
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4572-4579.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Korotkova, N., Yarova-Yarovaya, Y., Tchesnokova, V., Yazvenko, N., Carl, M. A., Stapleton, A. E., Moseley, S. L.
(2008). Escherichia coli DraE Adhesin-Associated Bacterial Internalization by Epithelial Cells Is Promoted Independently by Decay-Accelerating Factor and Carcinoembryonic Antigen-Related Cell Adhesion Molecule Binding and Does Not Require the DraD Invasin. Infect. Immun.
76: 3869-3880
[Abstract]
[Full Text]
-
Rosen, D. A., Hung, C.-S., Kline, K. A., Hultgren, S. J.
(2008). Streptozocin-Induced Diabetic Mouse Model of Urinary Tract Infection. Infect. Immun.
76: 4290-4298
[Abstract]
[Full Text]
-
Rosen, D. A., Pinkner, J. S., Jones, J. M., Walker, J. N., Clegg, S., Hultgren, S. J.
(2008). Utilization of an Intracellular Bacterial Community Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression. Infect. Immun.
76: 3337-3345
[Abstract]
[Full Text]
-
Kulesus, R. R., Diaz-Perez, K., Slechta, E. S., Eto, D. S., Mulvey, M. A.
(2008). Impact of the RNA Chaperone Hfq on the Fitness and Virulence Potential of Uropathogenic Escherichia coli. Infect. Immun.
76: 3019-3026
[Abstract]
[Full Text]
-
Rosen, D. A., Pinkner, J. S., Walker, J. N., Elam, J. S., Jones, J. M., Hultgren, S. J.
(2008). Molecular Variations in Klebsiella pneumoniae and Escherichia coli FimH Affect Function and Pathogenesis in the Urinary Tract. Infect. Immun.
76: 3346-3356
[Abstract]
[Full Text]
-
Wiles, T. J., Dhakal, B. K., Eto, D. S., Mulvey, M. A.
(2008). Inactivation of Host Akt/Protein Kinase B Signaling by Bacterial Pore-forming Toxins. Mol. Biol. Cell
19: 1427-1438
[Abstract]
[Full Text]
-
Feldmann, F., Sorsa, L. J., Hildinger, K., Schubert, S.
(2007). The Salmochelin Siderophore Receptor IroN Contributes to Invasion of Urothelial Cells by Extraintestinal Pathogenic Escherichia coli In Vitro. Infect. Immun.
75: 3183-3187
[Abstract]
[Full Text]
-
Flannagan, R. S., Aubert, D., Kooi, C., Sokol, P. A., Valvano, M. A.
(2007). Burkholderia cenocepacia Requires a Periplasmic HtrA Protease for Growth under Thermal and Osmotic Stress and for Survival In Vivo. Infect. Immun.
75: 1679-1689
[Abstract]
[Full Text]
-
Garofalo, C. K., Hooton, T. M., Martin, S. M., Stamm, W. E., Palermo, J. J., Gordon, J. I., Hultgren, S. J.
(2007). Escherichia coli from Urine of Female Patients with Urinary Tract Infections Is Competent for Intracellular Bacterial Community Formation. Infect. Immun.
75: 52-60
[Abstract]
[Full Text]
-
Justice, S. S., Hunstad, D. A., Seed, P. C., Hultgren, S. J.
(2006). Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA
103: 19884-19889
[Abstract]
[Full Text]
-
Miller, E., Garcia, T., Hultgren, S., Oberhauser, A. F.
(2006). The Mechanical Properties of E. coli Type 1 Pili Measured by Atomic Force Microscopy Techniques. Biophys. J
91: 3848-3856
[Abstract]
[Full Text]
-
Meiland, R., Geerlings, S. E., Stolk, R. P., Netten, P. M., Schneeberger, P. M., Hoepelman, A. I. M.
(2006). Asymptomatic Bacteriuria in Women With Diabetes Mellitus: Effect on Renal Function After 6 Years of Follow-up.. Arch Intern Med
166: 2222-2227
[Abstract]
[Full Text]
-
Mysorekar, I. U., Hultgren, S. J.
(2006). Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA
103: 14170-14175
[Abstract]
[Full Text]
-
Klumpp, D. J., Rycyk, M. T., Chen, M. C., Thumbikat, P., Sengupta, S., Schaeffer, A. J.
(2006). Uropathogenic Escherichia coli Induces Extrinsic and Intrinsic Cascades To Initiate Urothelial Apoptosis. Infect. Immun.
74: 5106-5113
[Abstract]
[Full Text]
-
Young, K. D.
(2006). The Selective Value of Bacterial Shape. Microbiol. Mol. Biol. Rev.
70: 660-703
[Abstract]
[Full Text]
-
Li, K., Feito, M. J., Sacks, S. H., Sheerin, N. S.
(2006). CD46 (Membrane Cofactor Protein) Acts as a Human Epithelial Cell Receptor for Internalization of Opsonized Uropathogenic Escherichia coli. J. Immunol.
177: 2543-2551
[Abstract]
[Full Text]
-
Justice, S. S., Lauer, S. R., Hultgren, S. J., Hunstad, D. A.
(2006). Maturation of Intracellular Escherichia coli Communities Requires SurA.. Infect. Immun.
74: 4793-4800
[Abstract]
[Full Text]
-
Ejrnaes, K., Sandvang, D., Lundgren, B., Ferry, S., Holm, S., Monsen, T., Lundholm, R., Frimodt-Moller, N.
(2006). Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women.. J. Clin. Microbiol.
44: 1776-1781
[Abstract]
[Full Text]
-
Chen, S. L., Hung, C.-S., Xu, J., Reigstad, C. S., Magrini, V., Sabo, A., Blasiar, D., Bieri, T., Meyer, R. R., Ozersky, P., Armstrong, J. R., Fulton, R. S., Latreille, J. P., Spieth, J., Hooton, T. M., Mardis, E. R., Hultgren, S. J., Gordon, J. I.
(2006). Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. Proc. Natl. Acad. Sci. USA
103: 5977-5982
[Abstract]
[Full Text]
-
Chauhan, A., Madiraju, M. V. V. S., Fol, M., Lofton, H., Maloney, E., Reynolds, R., Rajagopalan, M.
(2006). Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings.. J. Bacteriol.
188: 1856-1865
[Abstract]
[Full Text]
-
Thumbikat, P., Waltenbaugh, C., Schaeffer, A. J., Klumpp, D. J.
(2006). Antigen-specific responses accelerate bacterial clearance in the bladder.. J. Immunol.
176: 3080-3086
[Abstract]
[Full Text]
-
Bower, J. M., Mulvey, M. A.
(2006). Polyamine-Mediated Resistance of Uropathogenic Escherichia coli to Nitrosative Stress. J. Bacteriol.
188: 928-933
[Abstract]
[Full Text]
-
Bryan, A., Roesch, P., Davis, L., Moritz, R., Pellett, S., Welch, R. A.
(2006). Regulation of Type 1 Fimbriae by Unlinked FimB- and FimE-Like Recombinases in Uropathogenic Escherichia coli Strain CFT073. Infect. Immun.
74: 1072-1083
[Abstract]
[Full Text]
-
Justice, S. S., Hunstad, D. A., Harper, J. R., Duguay, A. R., Pinkner, J. S., Bann, J., Frieden, C., Silhavy, T. J., Hultgren, S. J.
(2005). Periplasmic Peptidyl Prolyl cis-trans Isomerases Are Not Essential for Viability, but SurA Is Required for Pilus Biogenesis in Escherichia coli. J. Bacteriol.
187: 7680-7686
[Abstract]
[Full Text]
-
Wright, K. J., Seed, P. C., Hultgren, S. J.
(2005). Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization. Infect. Immun.
73: 7657-7668
[Abstract]
[Full Text]
-
Darby, A. C., Chandler, S. M., Welburn, S. C., Douglas, A. E.
(2005). Aphid-Symbiotic Bacteria Cultured in Insect Cell Lines. Appl. Environ. Microbiol.
71: 4833-4839
[Abstract]
[Full Text]
-
Kadurugamuwa, J. L., Modi, K., Yu, J., Francis, K. P., Purchio, T., Contag, P. R.
(2005). Noninvasive Biophotonic Imaging for Monitoring of Catheter-Associated Urinary Tract Infections and Therapy in Mice. Infect. Immun.
73: 3878-3887
[Abstract]
[Full Text]
-
Hunstad, D. A., Justice, S. S., Hung, C. S., Lauer, S. R., Hultgren, S. J.
(2005). Suppression of Bladder Epithelial Cytokine Responses by Uropathogenic Escherichia coli. Infect. Immun.
73: 3999-4006
[Abstract]
[Full Text]
-
Marcusson, L. L., Olofsson, S. K., Lindgren, P. K., Cars, O., Hughes, D.
(2005). Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli. J Antimicrob Chemother
55: 938-943
[Abstract]
[Full Text]
-
Servin, A. L.
(2005). Pathogenesis of Afa/Dr Diffusely Adhering Escherichia coli. Clin. Microbiol. Rev.
18: 264-292
[Abstract]
[Full Text]
-
Kerrn, M. B., Struve, C., Blom, J., Frimodt-Moller, N., Krogfelt, K. A.
(2005). Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother
55: 383-386
[Abstract]
[Full Text]
-
Kucheria, R, Dasgupta, P, Sacks, S H, Khan, M S, Sheerin, N S
(2005). Urinary tract infections: new insights into a common problem. Postgrad. Med. J.
81: 83-86
[Abstract]
[Full Text]
-
Rudney, J.D., Chen, R., Sedgewick, G.J.
(2005). Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are Components of a Polymicrobial Intracellular Flora within Human Buccal Cells. J. Dent. Res.
84: 59-63
[Abstract]
[Full Text]
-
Jansen, A. M., Lockatell, V., Johnson, D. E., Mobley, H. L. T.
(2004). Mannose-Resistant Proteus-Like Fimbriae Are Produced by Most Proteus mirabilis Strains Infecting the Urinary Tract, Dictate the In Vivo Localization of Bacteria, and Contribute to Biofilm Formation. Infect. Immun.
72: 7294-7305
[Abstract]
[Full Text]
-
Feulner, J. A., Lu, M., Shelton, JohnM., Zhang, M., Richardson, J. A., Munford, R. S.
(2004). Identification of Acyloxyacyl Hydrolase, a Lipopolysaccharide- Detoxifying Enzyme, in the Murine Urinary Tract. Infect. Immun.
72: 3171-3178
[Abstract]
[Full Text]
-
Duncan, M. J., Li, G., Shin, J.-S., Carson, J. L., Abraham, S. N.
(2004). Bacterial Penetration of Bladder Epithelium through Lipid Rafts. J. Biol. Chem.
279: 18944-18951
[Abstract]
[Full Text]
-
Mo, L., Zhu, X.-H., Huang, H.-Y., Shapiro, E., Hasty, D. L., Wu, X.-R.
(2004). Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am. J. Physiol. Renal Physiol.
286: F795-F802
[Abstract]
[Full Text]
-
Justice, S. S., Hung, C., Theriot, J. A., Fletcher, D. A., Anderson, G. G., Footer, M. J., Hultgren, S. J.
(2004). From the Cover: Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA
101: 1333-1338
[Abstract]
[Full Text]
-
Anderson, M., Bollinger, D., Hagler, A., Hartwell, H., Rivers, B., Ward, K., Steck, T. R.
(2004). Viable but Nonculturable Bacteria Are Present in Mouse and Human Urine Specimens. J. Clin. Microbiol.
42: 753-758
[Abstract]
[Full Text]
-
Trulzsch, K., Hoffmann, H., Keller, C., Schubert, S., Bader, L., Heesemann, J., Roggenkamp, A.
(2003). Highly Resistant Metabolically Deficient Dwarf Mutant of Escherichia coli Is the Cause of a Chronic Urinary Tract Infection. J. Clin. Microbiol.
41: 5689-5694
[Abstract]
[Full Text]
-
Anderson, G. G., Palermo, J. J., Schilling, J. D., Roth, R., Heuser, J., Hultgren, S. J.
(2003). Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections. Science
301: 105-107
[Abstract]
[Full Text]
-
Bojesen, A. M., Torpdahl, M., Christensen, H., Olsen, J. E., Bisgaard, M.
(2003). Genetic Diversity of Gallibacterium anatis Isolates from Different Chicken Flocks. J. Clin. Microbiol.
41: 2737-2740
[Abstract]
[Full Text]
-
Poljakovic, M., Persson, K.
(2003). Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am. J. Physiol. Renal Physiol.
284: F22-F31
[Abstract]
[Full Text]
-
Schilling, J. D., Lorenz, R. G., Hultgren, S. J.
(2002). Effect of Trimethoprim-Sulfamethoxazole on Recurrent Bacteriuria and Bacterial Persistence in Mice Infected with Uropathogenic Escherichia coli. Infect. Immun.
70: 7042-7049
[Abstract]
[Full Text]
-
Saban, M. R., Nguyen, N.-B., Hammond, T. G., Saban, R.
(2002). Gene Expression Profiling of Mouse Bladder Inflammatory Responses to LPS, Substance P, and Antigen-Stimulation. Am. J. Pathol.
160: 2095-2110
[Abstract]
[Full Text]
-
Rosenberger, C. M., Finlay, B. B.
(2002). Macrophages Inhibit Salmonella Typhimurium Replication through MEK/ERK Kinase and Phagocyte NADPH Oxidase Activities. J. Biol. Chem.
277: 18753-18762
[Abstract]
[Full Text]
-
Mysorekar, I. U., Mulvey, M. A., Hultgren, S. J., Gordon, J. I.
(2002). Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli. J. Biol. Chem.
277: 7412-7419
[Abstract]
[Full Text]
-
Thomas, W., Ascott, Z. K., Harmey, D., Slice, L. W., Rozengurt, E., Lax, A. J.
(2001). Cytotoxic Necrotizing Factor from Escherichia coli Induces RhoA-Dependent Expression of the Cyclooxygenase-2 Gene. Infect. Immun.
69: 6839-6845
[Abstract]
[Full Text]